دورية أكاديمية

TREM2-Ligand Interactions in Health and Disease.

التفاصيل البيبلوغرافية
العنوان: TREM2-Ligand Interactions in Health and Disease.
المؤلفون: Kober DL; Molecular Microbiology and Microbial Pathogenesis Program, Washington University School of Medicine, St. Louis, MO 63110, USA; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA., Brett TJ; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, MO 63110, USA. Electronic address: tbrett@wustl.edu.
المصدر: Journal of molecular biology [J Mol Biol] 2017 Jun 02; Vol. 429 (11), pp. 1607-1629. Date of Electronic Publication: 2017 Apr 19.
نوع المنشور: Journal Article; Review; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 2985088R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1089-8638 (Electronic) Linking ISSN: 00222836 NLM ISO Abbreviation: J Mol Biol Subsets: MEDLINE
أسماء مطبوعة: Publication: Amsterdam : Elsevier
Original Publication: 1959- : London : Academic Press
مواضيع طبية MeSH: Health*, Membrane Glycoproteins/*metabolism , Neurodegenerative Diseases/*pathology , Receptors, Immunologic/*metabolism, Animals ; Disease Models, Animal ; Humans ; Protein Binding
مستخلص: The protein triggering receptor expressed on myeloid cells-2 (TREM2) is an immunomodulatory receptor with a central role in myeloid cell activation and survival. In recent years, the importance of TREM2 has been highlighted by the identification of coding variants that increase risk for Alzheimer's disease and other neurodegenerative diseases. Animal studies have further shown the importance of TREM2 in neurodegenerative and other inflammatory disease models including chronic obstructive pulmonary disease, multiple sclerosis, and stroke. A mechanistic understanding of TREM2 function remains elusive, however, due in part to the absence of conclusive information regarding the identity of endogenous TREM2 ligands. While many TREM2 ligands have been proposed, their physiological role and mechanism of engagement remain to be determined. In this review, we highlight the suggested roles of TREM2 in these diseases and the recent advances in our understanding of TREM2 and discuss putative TREM2-ligand interactions and their potential roles in signaling during health and disease. We develop a model based on the TREM2 structure to explain how different TREM2 ligands might interact with the receptor and how disease risk variants may alter ligand interactions. Finally, we propose future experimental directions to establish the role and importance of these different interactions on TREM2 function.
(Copyright © 2017 Elsevier Ltd. All rights reserved.)
References: Nat Rev Immunol. 2013 Nov;13(11):802-14. (PMID: 24319778)
Brain. 2008 Nov;131(Pt 11):3081-91. (PMID: 18790823)
Alzheimers Res Ther. 2016 Apr 27;8(1):17. (PMID: 27121148)
Alzheimers Dement. 2017 Apr;13(4):381-387. (PMID: 27520774)
Protein Sci. 2015 Jan;24(1):138-44. (PMID: 25377861)
J Leukoc Biol. 2011 Jan;89(1):11-9. (PMID: 20643813)
Alzheimers Dement. 2015 Dec;11(12 ):1407-16. (PMID: 25936935)
Blood. 2002 Nov 15;100(10):3822-4. (PMID: 12393607)
Sci Signal. 2010 May 18;3(122):ra38. (PMID: 20484116)
J Biol Chem. 2006 May 12;281(19):13396-403. (PMID: 16505478)
J Exp Med. 2003 Aug 18;198(4):645-51. (PMID: 12913093)
Nature. 2010 Oct 28;467(7319):1118-22. (PMID: 20877282)
Scand J Immunol. 2014 Mar;79(3):187-96. (PMID: 24383713)
PLoS Pathog. 2014 Jun 12;10(6):e1004167. (PMID: 24945405)
Immunity. 2005 Jan;22(1):31-42. (PMID: 15664157)
J Biol Chem. 2015 Oct 23;290(43):26033-42. (PMID: 26374897)
J Biol Chem. 1998 Dec 4;273(49):32934-42. (PMID: 9830044)
J Neurosci. 2011 May 11;31(19):7049-59. (PMID: 21562267)
Nat Cell Biol. 2006 Jun;8(6):615-22. (PMID: 16715077)
Sci Signal. 2013 Aug 20;6(289):ra72. (PMID: 23962980)
Mol Neurobiol. 2017 Mar;54(2):855-865. (PMID: 26780455)
J Cell Biol. 2009 Jan 26;184(2):215-23. (PMID: 19171755)
Neuron. 2016 May 18;90(4):724-39. (PMID: 27196974)
J Biol Chem. 2013 Nov 15;288(46):33027-36. (PMID: 24078628)
Neurobiol Aging. 2014 Apr;35(4):934.e7-10. (PMID: 24139279)
Mol Neurodegener. 2015 Oct 05;10:52. (PMID: 26438529)
Mol Neurodegener. 2014 Jun 03;9:20. (PMID: 24893973)
J Immunol. 2006 Sep 15;177(6):3520-4. (PMID: 16951310)
Nat Rev Neurosci. 2016 Apr;17(4):201-7. (PMID: 26911435)
Elife. 2016 Dec 20;5:null. (PMID: 27995897)
Sci Transl Med. 2014 Jul 2;6(243):243ra86. (PMID: 24990881)
Nature. 2012 May 3;485(7396):69-74. (PMID: 22522930)
Open Inflamm J. 2011 Oct 7;4:49-60. (PMID: 24765217)
J Immunol. 2007 Sep 15;179(6):4065-73. (PMID: 17785845)
Annu Rev Neurosci. 2012;35:369-89. (PMID: 22715882)
Science. 2016 May 6;352(6286):712-6. (PMID: 27033548)
Nat Rev Immunol. 2007 Nov;7(11):841-50. (PMID: 17960150)
N Engl J Med. 2013 Jan 10;368(2):107-16. (PMID: 23150908)
Cell. 2015 Mar 12;160(6):1061-71. (PMID: 25728668)
Neuron. 2016 Jul 20;91(2):328-40. (PMID: 27477018)
N Engl J Med. 2013 Jan 10;368(2):117-27. (PMID: 23150934)
J Biol Chem. 1998 Dec 18;273(51):34115-9. (PMID: 9852069)
J Immunol. 2006 Aug 15;177(4):2051-5. (PMID: 16887962)
J Bone Miner Res. 2006 Feb;21(2):237-45. (PMID: 16418779)
Nat Genet. 2000 Jul;25(3):357-61. (PMID: 10888890)
Sci Signal. 2015 Mar 24;8(369):ra31. (PMID: 25805889)
J Biol Chem. 2010 Jan 29;285(5):2976-85. (PMID: 19948717)
Neurobiol Aging. 2013 Dec;34(12):2699-714. (PMID: 23855984)
Hum Mutat. 2008 Sep;29(9):E194-204. (PMID: 18546367)
J Clin Invest. 2012 Apr;122(4):1156-63. (PMID: 22466657)
Nat Neurosci. 2015 Jun;18(6):800-6. (PMID: 26007213)
Nat Rev Immunol. 2007 Feb;7(2):155-61. (PMID: 17220916)
Glia. 2008 Oct;56(13):1438-47. (PMID: 18551625)
Immunogenetics. 2012 Jan;64(1):39-47. (PMID: 21800138)
Mol Neurobiol. 2016 Sep;53(7):4931-8. (PMID: 26365049)
Neurobiol Aging. 2014 Mar;35(3):726.e11-9. (PMID: 24119542)
Eur J Immunol. 2012 Jan;42(1):176-85. (PMID: 21956652)
Eur J Immunol. 2007 May;37(5):1290-301. (PMID: 17407101)
EMBO Mol Med. 2016 May 02;8(5):466-76. (PMID: 26941262)
ACS Chem Neurosci. 2016 Apr 20;7(4):420-7. (PMID: 26854967)
Mol Immunol. 2015 Aug;66(2):463-71. (PMID: 26021803)
J Immunol. 2012 Mar 15;188(6):2612-21. (PMID: 22312126)
J Exp Med. 2003 Aug 18;198(4):669-75. (PMID: 12925681)
Alzheimers Res Ther. 2013 May 21;5(3):24. (PMID: 23692967)
Vet Immunol Immunopathol. 2015 Feb 15;163(3-4):194-201. (PMID: 25563793)
Neuropsychopharmacology. 2014 Dec;39(13):2949-62. (PMID: 25047746)
Alzheimers Dement. 2016 Dec;12 (12 ):1259-1272. (PMID: 27423963)
J Exp Med. 2015 May 4;212(5):681-97. (PMID: 25897174)
Front Neurosci. 2017 Jan 18;10 :618. (PMID: 28149270)
Acta Neuropathol. 2016 Jun;131(6):925-33. (PMID: 26754641)
PLoS Med. 2007 Apr;4(4):e124. (PMID: 17425404)
Nat Neurosci. 2013 Dec;16(12):1896-905. (PMID: 24162652)
Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):6158-63. (PMID: 15073337)
Mol Cell. 2008 Aug 8;31(3):422-31. (PMID: 18691974)
Nat Rev Neurol. 2014 Apr;10(4):217-24. (PMID: 24638131)
J Biol Chem. 2015 Oct 23;290(43):26043-50. (PMID: 26374899)
J Exp Med. 2005 Feb 21;201(4):647-57. (PMID: 15728241)
J Neurochem. 2009 May;109(4):1144-56. (PMID: 19302484)
J Exp Med. 2016 May 2;213(5):667-75. (PMID: 27091843)
J Clin Immunol. 2014 Jul;34 Suppl 1:S64-9. (PMID: 24711006)
Nat Immunol. 2009 Jul;10(7):734-43. (PMID: 19503107)
Neuron. 2014 Feb 19;81(4):740-54. (PMID: 24559670)
Nat Immunol. 2010 Nov;11(11):1023-9. (PMID: 20890284)
J Neurosci. 2017 Jan 18;37(3):637-647. (PMID: 28100745)
J Exp Med. 2015 Mar 9;212(3):287-95. (PMID: 25732305)
J Biol Chem. 2015 Jun 12;290(24):14904-14. (PMID: 25869127)
Neurobiol Aging. 2015 May;36(5):1994-2003. (PMID: 25816748)
Immunity. 2007 Dec;27(6):927-40. (PMID: 18082433)
Neuron. 2013 Apr 24;78(2):256-68. (PMID: 23562540)
Traffic. 2015 May;16(5):510-8. (PMID: 25615530)
Mol Neurodegener. 2015 Apr 10;10:19. (PMID: 25886450)
Science. 2016 Aug 19;353(6301):777-83. (PMID: 27540165)
J Biol Chem. 2007 Mar 30;282(13):10018-27. (PMID: 17264079)
J Lipid Res. 2009 Apr;50 Suppl:S183-8. (PMID: 19106071)
PLoS One. 2013;8(1):e52982. (PMID: 23301011)
J Neurol Neurosurg Psychiatry. 2003 Jun;74(6):825-6. (PMID: 12754369)
Gastroenterology. 2013 Feb;144(2):346-356.e3. (PMID: 23108068)
Diabetes. 2015 Jan;64(1):117-27. (PMID: 25114293)
JAMA Neurol. 2013 Jan;70(1):78-84. (PMID: 23318515)
J Exp Med. 2001 Oct 15;194(8):1111-22. (PMID: 11602640)
Proc Natl Acad Sci U S A. 2014 Apr 15;111(15):E1463-72. (PMID: 24706780)
Immunity. 2000 Sep;13(3):345-53. (PMID: 11021532)
Neurobiol Aging. 2015 Dec;36(12):3176-86. (PMID: 26364736)
Am J Respir Crit Care Med. 2013 Jul 15;188(2):201-12. (PMID: 23721075)
J Biol Chem. 2012 Aug 24;287(35):29620-6. (PMID: 22761415)
Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4816-21. (PMID: 19251634)
Mol Neurodegener. 2013 Jun 21;8:19. (PMID: 23800361)
Alzheimers Dement. 2016 Jun;12(6):719-32. (PMID: 27179961)
EMBO Mol Med. 2016 Sep 01;8(9):992-1004. (PMID: 27402340)
Neurobiol Aging. 2014 Oct;35(10):2419.e23-5. (PMID: 24910390)
J Neuroinflammation. 2016 Jan 20;13:17. (PMID: 26792193)
Nature. 2009 Apr 30;458(7242):1191-5. (PMID: 19252480)
JAMA Neurol. 2014 Apr;71(4):449-53. (PMID: 24535663)
J Leukoc Biol. 2002 May;71(5):753-63. (PMID: 11994499)
Nature. 1998 Feb 12;391(6668):703-7. (PMID: 9490415)
FASEB J. 2015 Apr;29(4):1247-57. (PMID: 25477281)
Am J Hum Genet. 2002 Sep;71(3):656-62. (PMID: 12080485)
Dev Neurosci. 2004 Jan-Feb;26(1):1-10. (PMID: 15509893)
Blood. 2012 Mar 22;119(12):2799-809. (PMID: 22302738)
Sci Transl Med. 2016 Dec 14;8(369):369ra178. (PMID: 27974666)
Mol Neurodegener. 2016 Jan 12;11:3. (PMID: 26754172)
Hum Mol Genet. 2014 Nov 1;23(21):5838-46. (PMID: 24899047)
Neurology. 2001 Jun 12;56(11):1552-8. (PMID: 11402114)
Neurobiol Aging. 2013 Dec;34(12):2890.e1-5. (PMID: 23870839)
Curr Opin Immunol. 2009 Feb;21(1):38-46. (PMID: 19230638)
Ther Hypothermia Temp Manag. 2013 Dec 1;3(4):189-198. (PMID: 24380032)
Neuropharmacology. 2016 Jun;105:196-206. (PMID: 26802771)
Nat Rev Immunol. 2003 Jun;3(6):445-53. (PMID: 12776204)
Mol Immunol. 2015 Feb;63(2):595-9. (PMID: 25172093)
Neuron. 2016 Aug 3;91(3):548-60. (PMID: 27397516)
J Neurochem. 2009 Jul;110(1):284-94. (PMID: 19457124)
Nat Neurosci. 2014 Jan;17(1):131-43. (PMID: 24316888)
Acta Neuropathol. 2013 Oct;126(4):479-97. (PMID: 24052108)
Neurobiol Aging. 2013 Aug;34(8):2077.e11-8. (PMID: 23582655)
Invest Ophthalmol Vis Sci. 2013 May 17;54(5):3451-62. (PMID: 23611998)
J Neurosci. 2015 Feb 25;35(8):3384-96. (PMID: 25716838)
Biophys J. 2012 Apr 4;102(7):L27-9. (PMID: 22500771)
Structure. 2015 Sep 1;23(9):1621-31. (PMID: 26235028)
Acta Neuropathol. 2015 Mar;129(3):429-47. (PMID: 25631124)
J Neurosci. 2017 Feb 15;37(7):1772-1784. (PMID: 28077724)
Neurobiol Aging. 2014 Jun;35(6):1243-51. (PMID: 24368090)
Sci STKE. 2006 Jan 31;2006(320):re1. (PMID: 16449667)
Mucosal Immunol. 2008 May;1(3):229-38. (PMID: 19079182)
Neurology. 2005 May 10;64(9):1502-7. (PMID: 15883308)
Proc Natl Acad Sci U S A. 2009 Jan 6;106(1):256-61. (PMID: 19109436)
Blood. 2007 Aug 1;110(3):1029-35. (PMID: 17452516)
Infect Immun. 2008 Jun;76(6):2439-47. (PMID: 18391000)
Eur J Immunol. 2006 Jul;36(7):1646-53. (PMID: 16783855)
J Exp Med. 2017 Mar 6;214(3):597-607. (PMID: 28209725)
J Immunol. 2003 Jul 15;171(2):594-9. (PMID: 12847223)
Mol Immunol. 2015 Feb;63(2):574-8. (PMID: 25172092)
Eur J Neurosci. 2004 Nov;20(10):2617-28. (PMID: 15548205)
J Biol Chem. 2015 Jun 19;290(25):15866-77. (PMID: 25957402)
Res Rep Biochem. 2015;5:89-100. (PMID: 26478868)
Biophys J. 2013 Apr 2;104(7):1435-44. (PMID: 23561520)
J Clin Invest. 2015 May;125(5):2161-70. (PMID: 25893602)
Cell. 2013 Apr 25;153(3):707-20. (PMID: 23622250)
معلومات مُعتمدة: P50 AG005681 United States AG NIA NIH HHS; R01 HL119813 United States HL NHLBI NIH HHS; T32 GM007067 United States GM NIGMS NIH HHS
فهرسة مساهمة: Keywords: Alzheimer's disease; immune signaling; inflammation; microglia; neurodegeneration
المشرفين على المادة: 0 (Membrane Glycoproteins)
0 (Receptors, Immunologic)
0 (TREM2 protein, human)
تواريخ الأحداث: Date Created: 20170423 Date Completed: 20170712 Latest Revision: 20190106
رمز التحديث: 20221213
مُعرف محوري في PubMed: PMC5485854
DOI: 10.1016/j.jmb.2017.04.004
PMID: 28432014
قاعدة البيانات: MEDLINE
الوصف
تدمد:1089-8638
DOI:10.1016/j.jmb.2017.04.004